Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Gastroenterology Medicine & Research

Safety of Everolimus in Living Donor Liver Transplantation Recipients with Severe Renal Dysfunction with Low Estimated Glomerular Filtration Rate: Can Everolimus Help in Renal Recovery?

  • Open or Close Ashok Thorat*

    Medical University Hospital, China

    *Corresponding author: Ashok Thorat, Medical University Hospital, Yuh-Der Road, North District, Taichung, China

Submission: September 10, 2017; Published: December 15, 2017

DOI: 10.31031/GMR.2017.01.000505

ISSN 2637-7632
Volume1 Issue1

Abstract

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Switching from calcineurin inhibitors (CNIs) to non-nephrotoxic mammalian target of rapamycine inhibitors (mTORi) such as everolimus (EVR) can improve renal function in these patients. Single center prospective study by Castroagudín et al. [1] has shown an improvement of renal function after addition of the EVR to primary immunosuppression and reducing the CNIs [1].

Get access to the full text of this article